Atlas Trials

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

Clinical trial NCT06461351 · RECRUITING

Trial details

NCT number
NCT06461351
Sponsor
Juventas Cell Therapy Ltd.
Status
RECRUITING
Study type
OBSERVATIONAL
B-cell Tumors
Start date
2024-03-30
Primary completion
2039-05-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.